Premaitha Health (NIPT) Share Price, News & Analysis

Company Overview

Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company is headquartered in Manchester, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1.57 million shs
• Average Volume: 1.35 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NIPT Stock Analysis - Frequently Asked Questions

How were Premaitha Health's earnings last quarter?

Premaitha Health PLC (LON:NIPT) announced its quarterly earnings data on Friday, December, 29th. The company reported ($2.00) earnings per share (EPS) for the quarter. The firm had revenue of $2.71 million for the quarter.

How do I buy shares of Premaitha Health?

Shares of NIPT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Premaitha Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Premaitha Health investors own include IQE (IQE), Avanti Communications Group (AVN), Chesapeake Utilities (CPK), Plethora Solutions (PLE), Vedanta Resources (VED), Mitie Group (MTO) and Sirius Minerals (SXX).

Company Calendar

• Last Earnings: 12/29/2017
• Today: 8/29/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Laboratories & Research
• Sub-Industry: N/A
• Current Symbol: LON:NIPT
• Previous Symbol: LON:VIY
• CIK: N/A
• Web: www.premaitha.com
• Phone: +44-161-6676865
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A